20-03-2026 22:53 via drugs.com

FDA Provides Breakthrough Device Designation to MeMed BV Flex

FRIDAY, March 20, 2026-- The U.S. Food and Drug Administration has granted Breakthrough Device designation to MeMed BV Flex, a blood test that differentiates between bacterial and viral infections."This is the kind of diagnostic innovation health...
Read more »

Pharmaceutical news



Want To Stress Less? Start With These Everyday Habits
High Ambient Temperatures Linked to CKD Prevalence, ESKD Incidence
ACC: Hypertensive Heart Disease Mortality Increasing in Young Women
AHA: Sedentary Behavior, Light-Intensity Exercise Predictive of Hypertensive Disorders of Pregnancy
Injectable, Extended-Release Buprenorphine Feasible for Opioid Use Disorder During Pregnancy
Promoting Fluid Intake Does Not Reduce Recurrent Urinary Stone Events
Up to 155,000 COVID Deaths May Not Have Been Counted, Study Finds
FDA Drops Plan To Ban Tanning Beds for Minors Nationwide
People With Insomnia More Likely to Report Negative Effects With Use of Sleep Apps
Survey Shows More People Struggling To Afford ACA Insurance
Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds
Higher Meat Intake Tied to Better Cognitive Trajectories in Genetic Risk Group
Preconception, Prenatal Pesticide Exposure Linked to Low Apgar Scores
Early-Life Exposure to PFAS Linked to Bone Development in Adolescence
Desktop versie